Perrigo Israel (formerly Agis) develops, produces and markets generic drugs, active pharmaceutical ingredients (APIs), innovative dermatological products and consumer products. Perrigo Israel is a fully owned subsidiary of Perrigo, located in Allegan, Michigan, the world's largest manufacturer of over-the-counter (OTC) drugs and nutritional supplements sold to food marketing chains, drugstore chains and large wholesalers as store brands. Employing more than 6,000 workers worldwide, the company's primary markets and manufacturing facilities are in the United States, Israel, Europe and Mexico. Periggo Israel is one of the country's 25 largest industrial companies. More than two-thirds of the company's sales are made to the international market. Among the Perrigo pharmaceuticals sold in Israel are Testomax, Exidol, Agisten and Omacor. Perrigo is traded on NASDAQ (PRGO) and on the Tel Aviv Stock Exchange (PRGO.TA).